CPSA Shanghai in Review
CPSA Shanghai 2011 Shanghai, China
2011 Program Chair
Jing-Tao Wu, Millennium Pharmaceuticals
Plenary Lectures
Pete Smith, Senior Vice President, Millennium Pharmaceuticals
Challenges and Future Direction of Oncology Drug Development
Xiangmin Zhang, Fudan University
Multi-dimensional Chromatography-Mass Spectrometry for Protein Analysis
Keynote Lectures
Scott Obach, Pfizer
Stable and Reactive Metabolites in Drug Research
Lester C. Taylor, Shane Tichy, and Na Pi; Agilent Technologies
Simultaneous Determination of the PK Profile of Clozapine and its Metabolites in Rat Plasma Using a High-Resolution 6540 QTOF Instrument
Featured Symposia and Roundtables
- Comparison of Regulatory Requirments on DMPK Package
- Emerging Trends and Technologies in Pharmaceutical Sciences
- Dried Blood Spots and Other Emerging Bioanalytical Technologies
- Drug-Drug Interactions
- ADME Optimization to Advance CNS and Oncology Drug Discovery and Development:
Industry Case Studies - High-speed, High-Resolution Techniques for Pharmaceutical Analysis
- Analytical Approaches for the Determination of Low-Level Impurities to Comply
with International Regulations - Novel Drug Delivery Technologies
- Biomarker Analysis in Drug Discovery, Development and the Clinic
- Development of Biologics as Therapeutics
- PK/PD in Drug Discovery & Development
- Regulated Bioanalysis: State of the Art
- Current Issues in Regulated Bioanalysis
Young Scientist Excellence Award Recipients
Chunying Gao - Shanghai Institute of Materia Medica
Cen Xie - Shanghai Institute of Materia Medica
Weiwei Jia - Shanghai Institute of Materia Medica
Yang Li- GlaxoSmithKline R&D China
Yu Cai - Institute of Chinese Medical Sciences, University of Macau
John Zhang - Novartis Institute for Biomedical Research
CPSA Shanghai 2010 Shanghai, China
2010 Program Chair
Yining Zhao, Ph.D., Pfizer
Plenary Lectures
Charles Tong, Global CMC, Pfizer; George Reid, Analytical R&D, Pfizer
Challenges and Opportunities of Pharmaceutical Regulatory Environment for Analytical Sciences -
An Industrial Perspective
Li Hua, The Academy of Military Medical Sciences
DMPK in Drug Discovery and Development
Keynote Lectures
John Fjeldsted, Agilent Technologies
Chip-Based Technology to Enable Biomarker Analysis
Lester C. Taylor, Shane Tichy, and Na Pi; Agilent Technologies
Simultaneous Determination of the PK Profile of Clozapine and its Metabolites in Rat Plasma Using a High-Resolution 6540 QTOF Instrument
Featured Symposia and Roundtables
- From Data to Knowledge: ADME Data Integration in Drug Discovery
- Strategic Measurement and Utility of Biomarkers in the Drug Development Continuum
- Computational Tools in Support of Analytical Chemistry
- Future Direction for Bioanalysis
- Leveraging Chinese Research Capabilities to Enable Pharma R & D
- Early CMC Development in China
- Advanced Technologies in LC-MS